methylphenidate has been researched along with Acute Onset Vascular Dementia in 3 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylphenidate was well tolerated while galantamine produced gastrointestinal side effects in a considerable number of patients." | 2.94 | Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI. ( Barkhof, F; Groeneveld, GJ; Klaassen, ES; Leeuwis, AE; Leijenaar, JF; Prins, ND; Scheltens, P; van der Flier, WM; van Gerven, JMA; Weinstein, HC, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Leijenaar, JF | 1 |
| Groeneveld, GJ | 1 |
| Klaassen, ES | 1 |
| Leeuwis, AE | 1 |
| Scheltens, P | 1 |
| Weinstein, HC | 1 |
| van Gerven, JMA | 1 |
| Barkhof, F | 1 |
| van der Flier, WM | 1 |
| Prins, ND | 1 |
| Padala, PR | 1 |
| Burke, WJ | 1 |
| Bhatia, SC | 1 |
| Petty, F | 1 |
| Kruithof, H | 1 |
| Fluit, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Symptomatic Treatment of Vascular Cognitive Impairment[NCT02098824] | Phase 2/Phase 3 | 30 participants (Anticipated) | Interventional | 2014-02-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for methylphenidate and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
Topics: Aged; Central Nervous System Stimulants; Cognitive Dysfunction; Cross-Over Studies; Dementia, Vascul | 2020 |
2 other studies available for methylphenidate and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Treatment of apathy with methylphenidate.
Topics: Aged; Central Nervous System Stimulants; Dementia, Vascular; Depressive Disorder, Major; Drive; Fema | 2007 |
[Physician-assisted suicide of a patient suffering from a psycho- organic disorder].
Topics: Aged; Central Nervous System Stimulants; Chronic Disease; Dementia, Vascular; Ethics, Medical; Human | 1999 |